FORMULATION AND EVALUATION OF TASTE MASKED ORAL DISPERSIBLETABLET OF CIPROFLOXACIN WITH ION EXCHANGE RESIN by Pathak, Vishwas et al.
Pathak et al                                                                                                              Journal of Drug Delivery & Therapeutics. 2017; 7(7):8-11                       
ISSN: 2250-1177                                                                                [8]                                                                             CODEN (USA): JDDTAO 
Available online on 25.12.2017 at http://jddtonline.info 
Journal of Drug Delivery and Therapeutics 
Open Access to Pharmaceutical and Medical Research 
© 2011-17, publisher and licensee JDDT, This is an Open Access article which permits unrestricted 
non-commercial use, provided the original work is properly cited 
Open  Access                                                                                                                     Research Article 
FORMULATION AND EVALUATION OF TASTE MASKED ORAL 
DISPERSIBLE TABLET OF CIPROFLOXACIN WITH ION EXCHANGE 
RESIN 
Vishwas Pathak
1
, Govinda Bhatt
2
, Sapna Malviya
2
, Anil Kharia
2
 
1
IPS Academy, College of Pharmacy (Indore, MP), India 
2
Modern Institute of Pharmaceutical Sciences (Indore, MP), India 
E-mail address: vishwas.pathak@gmail.com 
 
ABSTRACT 
Bitter taste is one of the important formulation problems that are encountered with many drugs, like Ciprofloxacin. In modern times, 
the most improved & easy technique is to formulate tasteless complexes of ciprofloxacin with ion exchange resin (Indion 234). After 
acid activation and swelling in water, resin & ciprofloxacin (proper ratio) was stirred for definite time & unbound drug in filtrate was 
estimated spectrophotometrically and drug-loading efficiency was calculated. The molecular properties of drug complexes by FT-IR 
study confirm the complexation of ciprofloxacin with Indion 234. The influence of superdisintegrants, crospovidone and sodium 
starch glycolate on disintegration time, wetting time and water absorption ratio was studied.  
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INTRODUCTION: 
Taste is the ability to detect the flavour of substances 
like food, drugs etc. Taste is now considered an 
important factor governing the patient compliance
1
.The 
purpose of the research was to formulate tasteless 
complexes of ciprofloxacin with Indion 234 and to 
evaluate molecular properties of drug complexes
2
. 
Ciprofloxacin is a broad spectrum fluoroquinolone 
antibiotic. It has a narrow absorption window and is 
mainly absorbed in the proximal areas of GIT. The 
present study  is an attempt to select best possible 
combination of drug and disintegrating agent to 
formulate rapidly disintegrating tablet of ciprofloxacin  
which disintegrates faster thereby reducing the time of 
onset of action
3.
 
MATERIALS AND METHODS:  
Materials 
Ciprofloxacin, Croscarmellose Sodium, Crosspovidone, 
MCC, Mannitol, SLS, Saccharin Sodium, Orange 
Flavor, Talc, Magnesium Stearate. Drug-excipent 
interactions were studied by IR spectroscopy at Modern 
Laboratories, Pvt. Ltd., Indore. All other chemicals used 
were of analytical reagent grade. Double distilled water 
was used in entire study. 
Preparation of Oral Dispersible Tablet Drug-Resin 
Complex  
Formation of drug-resin complex 
The batch process was used for complexation. Drug-
resin complex was prepared by placing 10 g of activated 
resin in a beaker containing 300 ml deionized water and 
allowed to swell for 30 minutes. Accurately weighed 
drug (as per 1:1, 1:1.2, and 1:1.3, drug-resin ratio) was 
added and stirred for 30 minutes. On filtration, the 
residue was washed with 700 ml of deionised water. 
Unbound drug in filtrate was estimated at 278 nm and 
drug-loading efficiency was calculated.
 
Method of Complexation 
Selection of resins 
Resins were selected on the basis of the nature of drug 
and requirement of formulation. Depending on the basis 
of acidic and basic nature of the drug, cation and anion 
exchange resins can be used. In the present work, weak 
cation exchange resin Indion 234 was selected based on 
their Ion exchange capacity and used for the taste 
masking of model drug  
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Table 1: Different Compositions of Oral Disintegrating Tablets 
S.N. Ingredients Quantity of Ingredients (mg) 
F1 F2 F3 F4 F5 F6 F7 F8 
1 DRC Eq. to 100 mg of drug 235.1 235.1 235.1 235.1 235.1 235.1 235.1 235.1 
2 Croscarmellose Sodium 10.0 16.5 23.0 29.5 - - - - 
3 Crosspovidone - - - - 10.0 16.5 23.0 29.5 
4 MCC 17.0 17.0 17.0 17.0 17.0 17.0 17.0 17.0 
5 Mannitol 40.85 34.35 27.85 21.35 40.85 34.35 27.85 21.35 
6 SLS 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 
7 Saccharin Sodium 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 
8 Orange Flavour 8.0 8.0 8.0 8.0 8.0 8.0 8.0 8.0 
9 Talc 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 
10 Magnesium Stearate 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 
Total  weight of tablet 330 330 330 330 330 330 330 330 
 
Batch process 
Indion 234 resin in three different drug- resin ratios (1:1, 
1:1.2, and 1:1.3) was studied. Activated resins (Indion 
234) (10 g) were taken in a 1000 ml beaker; 300 ml of 
deionized water was added. The resins were allowed to 
swell in water for 30 min. Model drug (Ciprofloxacin) 
(10 gm) was added. The contents of beaker were stirred 
on a magnetic stirrer for 30 min. The complex was 
filtered using a whatman’s filter paper. The residue was 
further washed with 700 ml of deionized water to 
remove any unbound drug. The filtrate was then 
analyzed at 278 nm. By subtracting the quantity of 
unbound drug from the concentration of the drug 
solution added, the amount of bound drug was 
calculated. 
RESULTS AND DISCUSSION: 
Determination of threshold bitterness concentration 
of model drug (Ciprofloxacin) 
 
It was found that all the volunteers felt bitterness, after 
30 sec of time, for the concentration of 150μg/ml and 
above.
 
Table 2: Determination of threshold bitterness concentration
 
No. of 
Volunteer 
Concentration of Drug (µg/ml) 
Interpretation 
50 75 100 150 200 
01 1 1 1 2 3 
0= Good 
1=Tasteless 
2=Slightly Bitter 
3=Bitter 
02 1 1 1 2 3 
03 1 1 1 2 3 
04 1 1 1 2 3 
05 1 1 2 2 3 
06 1 1 1 2 3 
 
 
Process optimization 
The process to prepare drug-resin complex was 
optimized. Model drug (Ciprofloxacin) was loaded on 
ion exchange resin by batch process to optimize the 
drug-resin complex. 
In Vitro Taste Masking Evaluation: Results of In 
Vitrotaste masking evaluation of drug-resin complex are 
tabulated, it was revealed that the drug released in 
phosphate buffer pH 6.8 from drug-resin complex at the 
end of 120 sec was less than the threshold bitterness 
concentration of model drug (Ciprofloxacin) i.e.150 
µg/ml.  
Figure 1: Optimization of drug-resin ratio 
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Table 3: In Vitro Taste Masking Evaluation of Indion 234 
DRCs 
With Indion 234 
Time 
(in sec) 
Concentration (µg/ml) 
1 2 3 Average Concentration 
 
 
60 99.36 100.17 100.04 99.85 ± 0.435 
120 114.77 114.98 114.26 114.67  0.370 
 
a. Sensory Evaluation of Taste Masked drug-resin 
complex:When the drug-resin complexes were 
subjected to sensory evaluation by human volunteers, 
the volunteers did not feel any bitter taste after keeping 
the drug resin complex in mouth for 30 sec, which 
confirmed that bitter taste of model drug (Ciprofloxacin) 
was masked successfully. 
b. Determination of drug content 
 
Table 4: Determination of drug content from drug-resin complex 
S. N. Drug-resin complex % Drug content (in 30 
min) 
1 Drug-Indion 234 complex (1:1.3) 97.84  0.48 
 
c. Drug releases from drug-resin complex: The 
release of model drug (Ciprofloxacin)  from the drug-
resin complex was observed in deionizer water , salivary 
pH of 6.8 and at gastric pH of 1.2 . The results are given 
in the following Tables and figure. The results indicated 
that insignificant amount of drug (less than 0.3%) was 
released in demonized water in 30 min, indicating the 
stability of complexes. In vitro drug release in salivary 
pH 6.8 was less than 5% within 60 sec. The drug-resin 
complex is stable in salivary pH for a period of 
administration. The amount released is insufficient to 
impart bitter taste while the formulation passes through 
the mouth to further parts of gastrointestinal (GI) tract. 
At gastric pH of 1.2, model drug (Ciprofloxacin) was 
completely released in 30 min. 
Table 5: Drug release from drug-resin complex in 
deionised water 
S. N. Time (min) Percent drug release 
1 5 0.010±0.48 
2 10 0.058±0.74 
3 20 0.077±0.18 
4 30 0.091±0.18 
Table 6:  Drug release from drug resin complex at 
salivary pH 6.8 
S. N. Time (sec) Percent drug release 
1 15 2.14±0.72 
2 30 3.79±0.49 
3 60 4.46 ±0.86 
4 120 4.77±0.37 
 
d. Evaluation of oral disintegrating tablet 
Table 7: Post compression parameters of oral disintegrating tablets 
Formulation 
code 
Hardness 
(kg/cm
2
) 
Friability 
(%) 
Wetting Time 
(sec) 
In vitro Disintegration 
Time (sec) 
F1 2.97±0.45 0.512 88 ±1.21 65 ±1.26 
F2 2.99±0.41 0.447 72±1.41 53 ±1.34 
F3 2.94±0.38 0.411 62 ±1.35 39 ±1.67 
F4 3.01±0.37 0.276 46±1.02 32 ±1.01 
F5 2.55±0.49 0.534 76 ±1.61 59 ±1.23 
F6 2.67±0.61 0.476 60 ±0.98 40 ±1.64 
F7 2.79±0.17 0.379 40 ±1.11 28 ±1.89 
F8 2.68±0.45 0.345 34 ±1.94         22±1.91 
 
e. Dissolution test of ODT F7 in Phosphate Buffer pH 6.8 (at salivary pH): 
Dissolution testing of ODT F7 at salivary pH showed that at the end of 120 sec, less than 5% of drug was released 
which indicated adequate taste masking. 
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Table 8: In VitroDrug Release of Batch F7 in Phosphate Buffer pH 6.8 
S.N. Time (sec) % Drug Release Standard deviation 
1 0 0 ± 0.00 
2 5 0.66 ± 0.21 
3 10 1.33 ± 0.21 
4 20 1.83 ± 0.15 
5 30 2.64 ± 0.14 
6 60 3.76 ± 0.24 
7 120 4.37 ± 0.26 
 
 
Figure 2: Drug release from drug resin complex at pH 1.2 
 
CONCLUSION:               
Drug release from drug resin complex was less than 5% 
at salivary pH 6.8. Bitterness evaluation results made by 
the consensus of trained persons confirmed that the 
bitter taste of Model drug (Ciprofloxacin) was masked 
by complexation with Resin. Micromeritics properties of 
drug-resin complex were evaluated. Amongst the 
various batches studied, Drug:Resin complex was 
successfully formulated into oral disintegrating tablet by 
direct compression method. Amongst the different 
superdisintegrants, combination of two 
superdisintegrants indicated improved disintegration 
time. Various drug formulations were compared with 
respect to In Vitro disintegration time and in vitro drug 
release profile. Formulation F7 was found to be 
palatable with In Vitrodisintegration time of 28 sec. 
Dissolution studies showed complete release of F7 
within 30 minutes. In Vivotaste masking evaluation 
revealed that the oral disintegrating tablet was 
adequately taste masked and had a pleasant mouth 
feel.In conclusion, an effective and pleasant tasting oral 
disintegrating tablet, of model drug (Ciprofloxacin) 
exhibiting satisfactory disintegration time and 
dissolution profile, was formulated using Indion 234 as a 
taste masking agent and crospovidone as a 
superdisintegrant by direct compression method. 
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